Mingkai Chen

Prof. Dr. Mingkai Chen

1. Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2022 in World Journal of Gastroenterology
Verified
Journal Article
Open access
YLYuanbin Liu
Yuanbin Liu
MCMingkai Chen
Mingkai Chen
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions

5 August 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
CZChuanfei Zeng
Chuanfei Zeng
MCMingkai Chen
Mingkai Chen
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, insulin resistance, mitochondrial dysfunction, inflammation, and oxidative stress. As a group of NAD+-dependent III deacetylases, the sirtuin (SIRT1–7) family plays a very important role in regulating mitochondrial biogenesis and participates in the progress of NAFLD. SIRT family members are distributed in the nucleus, cytoplasm, and mitochondria; regulate hepatic fatty acid oxidation metabolism through different metabolic pathways and mechanisms; and participate in the regulation of mitochondrial energy metabolism. SIRT1 may improve NAFLD by regulating ROS, PGC-1α, SREBP-1c, FoxO1/3, STAT3, and AMPK to restore mitochondrial function and reduce steatosis of the liver. Other SIRT family members also play a role in regulating mitochondrial biogenesis, fatty acid oxidative metabolism, inflammation, and insulin resistance. Therefore, this paper comprehensively introduces the role of SIRT family in regulating mitochondrial biogenesis in the liver in NAFLD, aiming to further explain the importance of SIRT family in regulating mitochondrial function in the occurrence and development of NAFLD, and to provide ideas for the research and development of targeted drugs. Relatively speaking, the role of some SIRT family members in NAFLD is still insufficiently clear, and further research is needed.

1 June 2020 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PAPing An
Ping An
MJMengyao Ji
Mengyao Ji
HRHaixia Ren
Haixia Ren
JSJuan Su
Juan Su
NDNik Sheng Ding
Nik Sheng Ding
YDYijuan Ding
Yijuan Ding

10 January 2023 in Frontiers in Physiology
Verified
Journal Article
Open access
YLYuanbin Liu
Yuanbin Liu
MCMingkai Chen
Mingkai Chen
Adipose tissue has been shown to play a key role in energy metabolism and it has been shown to regulate metabolic homeostasis through the secretion of adipokines. Neuregulin 4 (Nrg4), a novel adipokine secreted mainly by brown adipose tissue (BAT), has recently been characterized as having an important effect on the regulation of energy homeostasis and glucolipid metabolism. Nrg4 can modulate BAT-related thermogenesis by increasing sympathetic innervation of adipose tissue and therefore has potential metabolic benefits. Nrg4 improves metabolic dysregulation in various metabolic diseases such as insulin resistance, obesity, non-alcoholic fatty liver disease, and diabetes through several mechanisms such as anti-inflammation, autophagy regulation, pro-angiogenesis, and lipid metabolism normalization. However, inconsistent findings are found regarding the effects of Nrg4 on metabolic diseases in clinical settings, and this heterogeneity needs to be further clarified by future studies. The potential metabolic protective effect of Nrg4 suggests that it may be a promising endocrine therapeutic target.

24 January 2022 in Hepatology
Verified
Journal Article
Closed access
PDF file
JHJianglong Han
Jianglong Han
BWBin Wang
Bin Wang
WLWenmin Liu
Wenmin Liu
SWShijie Wang
Shijie Wang
RCRuyan Chen
Ruyan Chen
ZFZhenming Fu
Zhenming Fu

17 March 2020 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
YXYong Xiao
Yong Xiao
HPHong Pan
Hong Pan
QSQian She
Qian She
FWFen Wang
Fen Wang
MCMingkai Chen
Mingkai Chen